Suchergebnisse - "Cailleteau, Roman"

PubPharm (6)

1

Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6) : a phase 3a, randomised, open-label, treat-to-target trial

enthalten in: Lancet (London, England) | 2023

von Russell-Jones, D. | Babazono, T. | Cailleteau, R. | +7

CommentIn: Lancet. 2023 Nov 4;402(10413):1598-1599. - PMID 37863082

2

Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes : a randomised crossover trial

enthalten in: Diabetologia | 2023

von Pieber, T. | Arfelt, K. | Cailleteau, R. | +6

3

Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

enthalten in: Diabetologia | 2023

von Pieber, T. | Arfelt, K. | Cailleteau, R. | +6

4

Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

enthalten in: Diabetologia | 2023

von Pieber, T. | Arfelt, K. | Cailleteau, R. | +6

5

Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

enthalten in: Diabetologia | 2023

von Pieber, T. | Arfelt, K. | Cailleteau, R. | +6

6

Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes

enthalten in: Diabetes, obesity & metabolism | 2023

von Philis-Tsimikas, A. | Bajaj, H. | Begtrup, K. | +6

1
[1]